A noteworthy article from the CIA’s Studies in Intelligence Journal, published in 1979 and declassified last year, describes the use of “remote medical diagnosis” for foreign intelligence purposes.
“Remote medical diagnosis is defined as the identification of the illnesses affecting a person without the benefit of a formal medical examination.”
The authors provide capsule accounts of CIA medical diagnoses of various world leaders, including French President Georges Pompidou, Algerian President Houari Boumediene, Soviet Premier Leonid Brezhnev, and Israeli Prime Minister Menahem Begin.
The technique, such as it is, is far from infallible, the authors note. Although Israeli Prime Minister Golda Meir suffered from malignant lymphoma for more than 12 years, “We had been entirely unaware that she had this lethal disease.”
See “Remote Medical Diagnosis: Monitoring the health of Very Important Patients,” Studies in Intelligence, Spring 1979 (1.2 MB PDF file) (thanks to AT).
Nuclear weapons budgeting is like agreeing to buying a house without knowing the sales price, the mortgage rate, or the monthly payment.
Employing a living approach to evidence synthesis, disseminated at a national level, is a streamlined way to enable evidence-based decision-making nationwide.
By providing essential funding mechanisms, the Bioeconomy Finance Program will reduce the risks inherent in biotechnology innovation, encouraging more private sector investment.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.